Market Overview

Benzinga's Top Downgrades

Share:
Related ATU
12 Biggest Mid-Day Losers For Friday
Benzinga's Top Upgrades, Downgrades For January 13, 2017
Related XYL
How To Trade The Expected Expansion In U.S. Infrastructure Spending
Mother Nature Will Determine Future Of Portfolio When It Comes To Climate Change Stocks
Free Market Capitalist January Dividend Income (Seeking Alpha)

Analysts at Citigroup downgraded Actuant (NYSE: ATU) from “buy” to “neutral.” Actuant's shares closed at $25.81 yesterday. Actuant's trailing-twelve-month ROE is 14.43%.

Analysts at Goldman downgraded Xylem (NYSE: XYL) from “neutral” to “sell.” Xylem's shares closed at $24.29 yesterday. Xylem's PEG ratio is 2.33.

Analysts at Bernstein downgraded Weatherford International Ltd (NYSE: WFT) from “outperform” to “market perform.” Weatherford's shares closed at $12.24 yesterday. Weatherford's trailing-twelve-month profit margin is 2.53%.

JMP Securities downgraded Anthera Pharmaceuticals (NASDAQ: ANTH) from “outperform” to “market perform.” Anthera Pharmaceuticals' shares closed at $2.75 yesterday. Anthera Pharmaceuticals' trailing-twelve-month ROA is -92.62%.

Latest Ratings for ATU

DateFirmActionFromTo
Jan 2017RBC CapitalDowngradesOutperformSector Perform
Nov 2016BairdUpgradesNeutralOutperform
Oct 2016BarclaysDowngradesEqual-WeightUnderweight

View More Analyst Ratings for ATU
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ATU + ANTH)

View Comments and Join the Discussion!